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ABSTRACT
Historically, major driving factors for the animal agriculture industry have been efficiency and
profitability. As demand for efficient food production has increased, the industry has focused
research efforts on ways to improve the rearing process. Current market demands are requiring
the industry to abandon some of the traditional tools it has used to maximize productivity.
However, developing alternative technologies are available which may fill the void.
Unfortunately, these alternatives are less well-described and the beneficial impacts they can have
are not fully understood. As the animal agriculture industry matures it is becoming evident that
consumers will continue to demand methods of production change to increase sustainability,
produce safer food, produce food that is perceived to be more natural, and improve welfare of
animals. In order to maintain profitability, companies have been very responsive to market
pressures. As customers demand a particular product, companies make efforts to fulfill demand,
or risk losing market share. The goal of the studies included herein is to determine what impact
selected socially acceptable, non-traditional technologies can have on the efficiencies of poultry
production. The first study evaluates suitability of a commercially available direct-fed microbial
(DFM) to replace traditional antibiotic growth promoters (AGP) in broiler feeds. This study
indicates that an effective DFM can replace traditional AGP in poultry feeds and also improve
growth efficiencies of poultry currently being grown without AGP. A second study evaluates the
effects of inclusion of a unique blend of organic acids in the drinking water of turkeys on body
weight loss during feed withdrawal and transport periods. The study suggests that by inclusion
of this specific organic acid blend in the drinking water prior to harvest, body weight was
positively affected in a manner that meaningfully impacts profitability. Taken together, these

studies present non-traditional alternatives for implementation by poultry producers in an effort
to meet consumer demands, improve welfare, and increase profitability.
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I.

INTRODUCTION
Recent trends in the animal agriculture industry have been transitioning to production

methods which are perceived to be more natural and sustainable. These trends are primarily
shaped by social pressures from consumers in the general public. As a result, the industry is
looking for ways to reduce or eliminate the inclusion of chemicals and compounds the general
public has begun to demand be removed from production practices. Antibiotic growth promoters
(AGP), in particular, have been singled out due to the emergence of antibiotic resistant bacteria,
its apparent association with food animals1, and the prevalence of negative press regarding these
organisms in popular media. While a driving force behind the movement is the consumers of
animal protein, in some cases government organizations have enacted bans on inclusion of AGP.
In 2006, a full ban on the use of AGP was enacted in the European Union2 and in 2011 South
Korea followed suit3. While these two cases are significant, the overall motivating factor to
industry has been consumer demand and the response of food providers to consumer trends.
Many popular restaurant chain companies such as McDonald’s, Kentucky Fried Chicken,
Wendy’s, Hardees, Subway and Chipotle have required suppliers to guarantee meat they
purchase has been grown without the use of AGP4. As a result of this demand, the animal
agriculture industry has been forced to re-evaluate production methods and search for sustainable
alternatives.
In addition to a consumer driven shift in how poultry are produced, a major upcoming
challenge the poultry industry will face is the projected increase in demand for product in the
next 40 years. Current projections suggest that by 2050 demand for food in the world will
increase by 100%5,6. Industries providing high value animal protein will be under extreme
pressure to meet rising needs of a global middle class projected to grow by 3 billion people7,8.
1

Asia’s middle class is growing most rapidly and is set to represent 66% of the global middle
class population and account for 59% of middle class consumption by 2030, up from its current
rates of 28% and 23%, respectively7. These emerging middle class markets will be the primary
drivers for increased demand for animal proteins, as diet is one of the first areas to improve as
income levels rise8,9. Poultry is often a protein of choice for emerging middle class consumers,
and it is predicted to grow the fastest of all animal agriculture sectors8.
Such a large projected growth in consumption in combination with restrictions on modern
production methods, such as removal of AGP, will require the poultry industry to take a forward
look and determine the most efficient way to supply the market demands. Serious consideration
and scientific effort needs to occur to determine the best path forward. The objective of the
enclosed body of work is to determine what impact the use of non-traditional technologies might
have on modern poultry production. These technologies would need to meet the criteria of a
discerning market that is focused on removal of chemotherapy and improving animal welfare
practices of the animal agriculture business. In order to be widely accepted, these technologies
would need to improve the efficiency and costs associated with raising poultry.
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II.

LITERATURE REVIEW

History of the Poultry Industry
Over the last century, the poultry industry has grown from a locally oriented businesses
into a highly efficient, vertically integrated, progressive industry supplying product to a global
market1, 2. The poultry industry, unlike many other animal agriculture industries, is highly
structured with integrated control. From eggs to packaged food, the entire process is often
controlled by a single company, including the feed which is consumed by the animals.
Prior to the 1920s the majority of poultry were backyard flocks intended to supply eggs
and meat for a family with a few larger flocks that would supply eggs and meat locally1,3.
Poultry products were only available seasonally due to limited knowledge of poultry physiology
and nutrition. In the 1920s, demand for eggs increased resulting in an excess of male chickens3.
These male chickens were fed and sold for meat, becoming the earliest form of the modern
broiler3. It was observed that some of these chickens grew more rapidly than others, and some
were better suited for producing eggs3. These observations led to the earliest work in poultry
genetics, which resulted in development of the commercial birds used today4. The poultry
industry, as we would recognize today, began taking shape in the 1940s. Until 1942 meat
chickens were typically sold “New York dressed”, with only the blood and feathers removed,
until an Illinois plant was the first to win government approval of “on-line” evisceration1. It was
also during the 1940s that the first integrated operations began taking shape, consolidating feed
mills, hatcheries and processing plants1,3. By the 1960s greater than 90% of poultry produced in
the United States came from integrated poultry companies1,3. In 1949 the United States
Department of Agriculture (USDA) established the first quality standards for processed poultry,
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and in 1959 federal inspection became mandatory1,3. By the 1970s, the poultry industry closely
resembled todays’, being highly automated, mechanized, utilizing specially selected genetic
lines, and implementing strict nutritional and disease control programs1,3. The ability of the
industry to provide economically priced, desirable packaged food to consumers resulted in
chicken surpassing pork consumption in 1985 and beef by 1992 to become the most popular
animal protein in the United States1,3. USDA 2010 statistics list the broiler market in the United
States alone as worth more than $45 billion, providing more than 36 billion pounds of meat
annually5. In order to meet high consumer demand in a market with low profit margins, poultry
are reared in large densely packed houses typically containing greater than 10,000 birds, making
a single flock worth thousands of dollars, in many instances over $100,000 on farms containing
multiple houses, thus making control of disease a top priority5,6.
Enteric Disease
Disease can be defined as any deviation or interruption of the normal structure or
function of any part, organ or system within the host7. Enteric disease refers to disease of the
gastrointestinal tract (GIT)7. In poultry production enteric disease results in the loss of
productivity, an increase in mortality, and an increase in the potential for human health risks
associated with food borne illness8. All of these contribute to increases in the cost associated
with poultry production8. Digestion and absorption of nutrients, primary roles of the GIT, are
affected by transit time of ingesta, pH, and changes in net absorption of water7. The GIT also
acts as a barrier, protecting internal organs from exposure to pathogens found in the lumen. The
GIT represents the largest mass of lymphoid tissue in the body, known as the gut associated
lymphoid tissue (GALT)9. Pathogens are forced to contend with many natural defenses of the
host to cause disease. Low gastric pH, rapid transit through portions of the GIT, competitive
5

intestinal microbiota, and GALT all act in an effort to prevent pathogens from causing disease.
In addition to insult from pathogens (bacterial, viral, fungal, parasitic), enteric disease can be
caused by nutritional factors, stress, injury, and ingestion of toxins. These factors, if not causing
disease outright, can leave a host more susceptible to disease10. The severity and duration of
stress factors, such as suboptimal temperatures, poor environmental conditions, and improper
handling can also influence susceptibility to disease10.
Normal Microflora of the Gastrointestinal Tract
The GIT of warm blooded vertebrates constitutes one of the most diverse and densely
populated ecosystems known. The number of organisms present in the GIT exceed the number
of cells in the body by a factor greater than 1011,12, and total microbial content of the GIT has
been estimated to contain 1013-1014 organisms12,13. Since the incorporation of molecular
techniques, research indicates greater than 500 species of bacteria are present in the GIT, the
majority of which have not been cultured13,14. The GIT of poultry is often anatomically split into
the ileum and cecum. Lu et al found that Lactobacillus was the predominate genus of bacteria in
the ileum and 65% of cecal microflora were of the Clostridiaceae family13. The microbial
ecology of the poultry GIT has been shown to vary according to bird type, diet, age, and by
anatomical region13,15,16. Despite the variability the predominant organisms in the GIT of poultry
have been shown to be Gram positive anaerobes13,16. The majority of microflora present in the
GIT are beneficial to the host by providing nutrients through their own digestive process and
restricting the growth of pathogens, as discussed in more detail below15,17. Evidence also
indicates gut microflora modulate enteric immune function18, and are involved in maturation of
the immune system19. Full understanding of the complex role the microflora in the GIT play is
not yet fully understood.
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History of AGP in Poultry Production
The term “antibiotic” was first used by Selman Waksman in reference to antagonistic
substances with the capability to inhibit or kill other bacteria and fungi20. The most famous
antibiotic to be characterized is probably penicillin, discovered by Sir Alexander Fleming in
1928 for which he won the Nobel Prize in Physiology or Medicine in 194521. Fleming’s work is
said to be the inspiration for Waksman’s research, which resulted in the discovery of
streptomycin, for which he was awarded a Nobel prize in 195222. The ability of antibiotics to
increase growth rates in experimental animals was first observed in 1942 by Black et al23, and
Nielsen and Elvehjem24. In 1946 Moore et al first reported an improvement in the growth rate of
poultry with the inclusion of an antibiotic in studies attempting to determine baseline vitamin
requirements of poultry by eliminating microbial interference25. Moore observed that contrary to
the hypothesis that antibiotics would sterilize the intestine, the total number of recoverable
organisms did not change25. Although the drugs failed to create sterile conditions in the
intestinal tract, sulfasuxidine and streptomycin, given in combination with additional dietary
folic acid, reversed the negative growth effects produced by administering these drugs alone as
well as the negative effects in chicks given only folic acid25. It was also observed that by
inclusion of antibiotics and supplementary folic acid in the diet the predominate organism in the
feces shifted from coliforms to Lactobacilli25. This observation may give key insight into why
performance enhancement associated with AGP often is very similar in both frequency and
magnitude to those observed with probiotic administration.
This research was part of a greater effort occurring in the 1940s, which resulted in the
development of modern poultry production. Focused research was responsible for significant
advancements in nutrition, genetics, management and marketing during this time period26,27.
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These advancements established the poultry industry as a large scale, highly efficient system to
provide food to a growing market1-3. It also led to new challenges associated with nutrition and
disease. It was during this time that much of our current understanding of poultry production
was developed. As demand and availability for animal feed ingredients changed, new sources of
feed ingredients were evaluated. In a series of evaluations, research indicated that incorporation
of dried mycelia of the fungus Streptomyces aureofaciens acted as a growth promoter in poultry,
later it was discovered that these dried mycelia contained the antibiotic
chlorotetracycline28,29,30,31,26. The United States Food and Drug Administration (FDA) approved
use of antibiotics as animal feed additives without the need for a veterinary prescription in
195126.
Following the approval of antibiotics for use as non-prescription feed additives a great
deal of experimental data documenting the impact of inclusion of various antibiotics on body
weight was generated. Heth and Bird published a summary of trials occurring from 1950-1953
which report 8.5% increased BW in chickens fed diets containing 4 to 35 mg/kg procaine
penicillin, and improvements of 8.8% in experiments occurring between 1956 and 196032.
Increases in growth rate of 12.3% were observed in chickens consuming diets containing 10 to
35 mg/kg of tetracycline from 1950-1953, and 10.2% in experiments from 1956-196032. From
1956 to 1959, 10 to 35 mg/kg zinc bacitracin improved growth by 6%, and 100 mg by 15%32. In
1980 Bird summarized data from multiple investigators examining the growth promoting effects
of antibiotics between 1968 and 198033. These data indicated that feeding penicillin resulted in
an average BW increase of 11%, tetracyclines increased BW by 8-10%, and 4-7% average
increase in BW for “new” antibiotics was observed33. “New” antibiotics referred to lincomycin,
bambermycin, and tylosin33. Dafwang et al reported similar results in a series of studies
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conducted between 1981 and 1982 when they used the maximum approved rate of application
for penicillin, oxytetracycline, lincomycin, bambermycin, and tylosin.34. Average BW
improvement of birds consuming feed containing penicillin was reported as 10.4%, 11.5% for
diets containing oxytetracycline, 10% for diets containing lincomycin, 14.3% for bambermycin
containing diets, and 18.5% for diets containing tylosin. The number of reports showing positive
growth response to AGP promoted their universal adoption by modern animal agriculture.
Unlike therapeutic administration, an AGP is administered at sub-therapeutic dosages for a
prolonged period of time with the intent of improving growth rates, meat quality, and efficiency
in animals intended for food production.
In more recent studies, data suggests the positive effects of AGP have become less
profound35. This trend is hypothesized to be a result of further improvements in management,
genetics, and facilities35. Opponents to the use of AGP argue that the practice increases the risk
of endemic bacterial populations developing resistance to the antibiotics, which is one potential
hypothesis for the apparent the loss of efficacy of these compounds. As early as 1954 there was
evidence indicating that consistently feeding an AGP for several years could result in loss of its
ability to have a positive growth effect36,37. This loss of efficacy was shown to be reversible by
the substitution of a different AGP, indicating the problem might be associated with development
of resistance38. Indications of emerging antimicrobial resistance in animals intended for food
began as early as 1951 with turkeys being fed streptomycin39. Similarly, resistance was observed
in chickens fed tetracycline as an AGP in 1958 and 195922.
Currently, there are 32 antimicrobial compounds approved by the FDA for use in broiler
feeds without a veterinary prescription, 15 are listed for treatment of coccidiosis, 11 are listed as
growth promoters, and six are listed for other purposes26. Seven of these compounds (bacitracin,
9

chlortetracycline, erythromycin, lincomycin, novobiocin, oxytetracycline, and penicillin) are
used in both animal feeds and human medicine26. The public debate about the prudence of using
antibiotics as growth promoters has been well documented, and both sides of the debate have
extensive scientific data to support their arguments. Unfortunately there is little unbiased data
available on the risks associated with AGP usage26. There is clear data supporting the emergence
of resistance to an antibiotic in a population after it is commonly used for a period of time, and
this has been well documented in poultry39,40. The argument has centered on the impact of these
resistances and if they are transferred between human and animal populations. One of the main
points of justification for proponents of AGP centers on Avoparcin41, a glycopeptide structurally
related to vancomycin and teicoplanin, that was widely used in Europe as a growth promoter
from the early 1970s until it was fully banned in 199741. Avoparcin was never used as an AGP
in the United States42. Vancomycin-resistant Enterococci (VRE) were first reported in the mid1980s and are now an important cause of nosocomial infections43,44,45,46. The fact that VRE are
found in both Europe and the USA is used to argue that antimicrobial resistance is not a problem
resulting from AGP usage, rather, it is a result of therapeutic use, primarily in human medicine47.
Supporters of AGP have held to the belief that while resistance has developed to antibiotics used
as AGP, removal of AGP would result in a greater risks to human and animal health than what is
currently attributed to AGP use47,48. Antibiotic growth promotors have important prophylactic
activity and their withdrawal is now associated with a deterioration in animal health, including
increased diarrhea, weight loss and mortality due to Escherichia coli and Lawsonia
intracellularis in early post-weaning pigs, and clostridial necrotic enteritis in broilers47. A
directly attributable effect of these infections is the increase in usage of therapeutic antibiotics in
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diseased animals, including those of importance in human medicine such as tetracycline,
aminoglycosides, trimethoprim, macrolides and lincosamides47,48.
Opponents to the use of AGP also cite the example of Avoparcin. Vancomycin-resistant
enterococci have not been isolated from healthy individuals and farm animals in the United
States49,50. The primary source of VRE in the United States is hospital acquired infections42. In
contrast, 12% of healthy individuals in Europe have been found to test positive for VRE51. This
is argued to mean that while the problem is severe in the United States, it threatens only a small
percentage of the population as compared to Europe51.
Similar versions of this argument are ongoing throughout the scientific community, and
due to the lack of peer reviewed literature and well planned and executed studies it is unlikely to
be settled in the near future41,26. It is not the intent of this dissertation to argue the merits or risks
of AGP usage, but rather to discuss the impact that alternatives might have in the event a poultry
producer elects to use them or in the event they are removed from use in food animals by the
FDA.
Future of AGP use in Poultry Production
The current rate of AGP use in animal agriculture is unlikely to continue in the future.
Scientific and public scrutiny of the administration of therapeutic and sub-therapeutic doses of
antimicrobials to animals has increased consistently since the release of the Swann report in the
United Kingdom in 196952. This report recommended that antibiotics used to treat infections in
humans not be used as animal-feed additives53. As time has passed the level of scrutiny has
increased. In 1986, Sweden was the first country to ban the use of AGP in animal
agriculture47,54. Denmark followed suit and restricted the use of various antibiotics and AGP
11

until a full ban of all AGP was enacted in 200055. These bans were a result of data that
suggested the use of AGP could increase the instance of resistance genes found in the microbial
population and as a result pose a threat to human health56,57. In response to this potential threat,
the World Health Organization and the Economic and Social Commission of the European
Union (EU) publically stated that the use of antimicrobials in animals intended for food was a
public health concern57. As a result of this proclamation, the EU formally put forth a plan to
eliminate all AGP use in animal agriculture by January 1, 2006 in each member state58. Since
that time only South Korea has formally restricted the use of all AGP in 201159. The world’s
largest poultry producer, the United States, has made only limited efforts to restrict the use of
antimicrobials and AGP. To date the only major action taken with regards to antibiotic use in
animals was the complete prohibition in 2005 of fluoroquinolone use in animals due to the
importance of floroquinolones in human health56. While having no formal ban in the United
States, there has been a consumer driven demand to remove AGP from use. The social trend is
driven by consumers and implemented primarily by large food service providers, such as
McDonald’s, Kentucky Fried Chicken, Wendy’s, Hardees, Subway and Chipotle who are
demanding meat providers to supply AGP free products60. This trend has been gaining
momentum over the past decade and shows little sign of abating.
The scientific debate over the use of AGP is largely irrelevant to the negative public
perception of AGP usage. As a result the poultry industry has been, and will continue, to be
asked to limit the use of AGP and to seek alternatives.
Proposed Mechanism of Action of AGP
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There is universal agreement from the scientific community that the mechanism of action
of AGP is not well known. Conventionally, there have been four hypotheses put forth as to the
mechanism of action: 1) AGP inhibit endemic subclinical infection, thus reducing the metabolic
costs of the innate immune system; 2) they reduce microbial produced metabolites that inhibit
growth rate (such as ammonia and bile degradation products); 3) they reduce microbial use of
nutrients; and 4) they enhance the uptake and use of nutrients, because the intestinal wall in
AGP-fed animals is thinner61,55,62. The underlying hypothesis is that the intestinal microflora is
responsible for depression of animal growth and that the AGP through its control of the
microflora is mitigating the negative effects.
An emerging hypothesis suggests reduced enteric inflammation is responsible for benefits
associated with the addition of AGP63. Intestinal imbalances often are the result of changes, such
as diet, infection, or even stresses that affect the intestinal microflora. All of these situations are
commonly found in animal agriculture. When these imbalances occur, inflammation in the
intestinal tract is increased and enteric bacterial populations are in a state of flux64. Niewold has
argued that the effects of AGP on gut microflora may be due to effects on gut inflammatory
status, rather than direct effects on the microflora63. Central to the hypothesis of Niewold, is that
AGP may not benefit animals directly through an antimicrobial effect because they are provided
at sub-minimal inhibitory concentrations, levels known to not inhibit affected pathogens within
the ingesta of poultry. Additionally, the ability of antibiotics to affect growth rate and
performance, regardless of the class of antibiotics used, and their target bacterial populations,
suggests that the effects may not be directly due to antimicrobial activity. The microbial
populations of the intestinal tract are extremely diverse, and as the animal ages research indicates
gut associated microbial populations experience a great deal of change, becoming more and more
13

complex13. It seems unlikely that a single AGP could exhibit a consistent positive growth
response in such a situation. Niewold also pointed out that many popular AGP are classes that
accumulate in phagocytes with known attenuation of the innate inflammatory response. This
hypothesis is consistent with the observation that intestinal walls of AGP-fed animals are thinner,
which could be attributed to a reduced influx and accumulation of inflammatory cells65.
Additionally, it has been show that AGP have little effect on the intestinal microbiota
populations, especially in the cecum. Though differences in populations of the ileum between
AGP-fed and antibiotic free birds were noted, this may have been affected by other diet
differences and could be attributed to the rapidly changing microbial population dynamics of the
GIT66. The hypothesis put forth by Niewold could potentially explain the inconsistencies found
by researchers investigating the loss of efficacy of some AGP over time. It can also be noted
that there is a positive correlation with antibiotics that are used as AGP and anti-inflammatory
capability63. Therefore, it may be possible that AGP act on the host, rather than the intestinal
microflora.
Alternatives to AGP
As more sophisticated assays are developed, the scientific community will gain a better
understanding of AGP. It has been argued that until we have a more full understanding of the
true mechanism(s) of action our efforts to find alternatives to AGP will be handicapped63.
However, as restrictions to AGP have become more prevalent, producers have turned to several
technologies as alternatives to increase the efficiency of rearing food animals. These
technologies include exogenous enzymes, organic acids, probiotics (direct-fed microbials),
prebiotics, and herbal extracts or essential oils. These additives are intended to address a number

14

of areas impacted by AGP64. This dissertation will focus primarily on probiotics as an
alternative to AGP use; other alternatives will be only briefly discussed.
Exogenous enzymes
Growth promoting exogenous enzymes are primarily intended to act on non-starch
polysaccharides (NSPs) which have been shown to have a negative impact on animal
performance when included in the diet at high levels67.

Non-starch polysaccharides, often

referred to as dietary fiber in human nutrition, are a complex family of chemical structures that
are found in the indigestible portion of food derived primarily from plants. These compounds
include celluloses, pectins, oligosaccharides, arabinoxylans, and beta glucan64. Non-starch
polysaccharides in animal diets are derived most commonly from the cereal components of the
ration. Cereals vary in what NSPs are present, and the solubility of each NSP varies. Research
indicates that solubility is correlated to the negative impact an NSP has on performance, higher
solubility increases the negative impact68. Non-starch polysaccharides exert an anti-nutritive
effect in poultry due to their viscous nature68. Soluble NSPs increase the bulk and viscosity of
the ingesta, which decreases the rate of diffusion of both nutrients and enzymes, limiting the
interaction of ingesta with the mucosal surface of the gut68. As a result, retention time of ingesta
is prolonged in the small intestine and the rate of microbial fermentation is increased, placing the
gut microbiome in direct competition with the animal for nutrients68. The rates at which these
effects occur vary depending on the content, solubility, and family of NSP in the diet.
Incorporation of AGP into NSP-containing diets have shown to mitigate the problem69.
Inclusion of exogenous enzymes, such as xylanase in wheat based diets and beta-glucanase in
barley based diets, has been shown to markedly reduce the negative impacts of diets high in
NSPs67,68.
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Organic Acids
Organic acids (OA) are compounds that primarily include saturated straight-chain
monocarboxylic acids and their respective derivatives, and are often referred to as fatty acids,
volatile fatty acids, or weak or carboxylic acids70,71. Some of the most commonly used OA in
food and feed additives are: propionic, acetic, citric, lactic, tannic, and butyric. They possess
many properties that make them good candidates for alternatives to AGP, including
antimicrobial and anti-inflammatory properties72. They also exhibit a large number of gut
associated host effects64,72,73. Organic acids are weak acids by nature and pH is directly
correlated with their ability to kill microbes because of the effect on concentration of
undissociated acid71. Undissociated forms of OA can easily pass through the lipid membrane
layer of bacterial cell walls and once internalized into the neutral pH of the protoplasm, they
dissociate into anions and protons74. The increased proton concentration in the protoplasm
requires the cell to expend energy through the ATP-driven proton pump to maintain a specific
internal pH71. The end result can be impairment of cell function, death via energy depletion,
and/or lysis71. Potential targets of OA include the cell wall, cytoplasmic membrane, and specific
metabolic functions in the cytoplasm associated with replication, protein synthesis, and nutrient
transport functions75,71. The antimicrobial activity of OA are influenced mainly by the following
variables: (1) chemical formula, (2) pKa value of the acid, (3) chemical form (esterified or not,
acid, salt, coated or not), (4) molecular weight, (5) the acid specific minimum inhibitory
concentration (MIC) for the target microorganism, (6) the nature of the microorganism, (7)
animal species, and (8) buffering capacity of the diet76,77. Each acid has its own spectrum of
microbial activity related to these factors. Also, additive effects of acids are possible. There are
indications that the medium chain fatty acids may improve the efficacy of short chain fatty acids
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in controlling microbial populations64. In the field, mixtures of OA are mainly used, which
makes their spectrum broader and combines the good qualities of different acids78,73.
Physical form of the acids also plays a role in the AGP-replacement effect. The coating or
micro-encapsulation of fatty acids with a progressive ‘slow release’ matrix is essential for their
antimicrobial activity throughout the distal part of the GIT due to the fact that many organic
acids can be rapidly absorbed and used directly as energy sources64,73,79. In addition to the
antimicrobial properties of organic acids, their ability to act as a direct source of energy to
gastrointestinal mucosa has been proposed as a potential explanation for the positive growth
effects in livestock64,73. It has been well documented that OA exert a wide variety of effects on
intestinal function in animals64,72,73. These include increased rates of mucosal development, and
stimulation of epithelial cell proliferation and differentiation80. Additionally, OA also have
documented anti-inflammatory effects and are central to maintaining intestinal integrity81,64,73.
Thus for some acids, not only antibacterial, but also host effects can play a role in the AGPreplacement effect.
Probiotics
The beneficial effects of bacteria have been observed extensively throughout human
history. Modern scientific investigation of beneficial bacteria are founded in the works of Nobel
prize winner Eli Metchnikoff, who promoted the idea that yogurt and the bacteria it contained
contributed to the longevity of Bulgarian peasants82. Over time these beneficial bacterial
cultures have been referred to using different terms including, competitive exclusion cultures,
probiotics and direct-fed microbials83. Most recently the term probiotic has become ascendant.
The term “direct-fed microbial” is commonly differentiated as referring to beneficial live
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microorganisms that are consumed in the feed of animals intended for food production and is
often used synonymously with probiotic. Probiotics can be defined as live microorganisms
which when administered in adequate amounts confer a health benefit on the host84. The
beneficial effects may include the reduction or exclusion of pathogenic bacteria, and has been
previously referred to as competitive exclusion (CE) by Jaeger in 197485. The term CE has also
been adopted to describe a similar phenomenon first described by Nurmi and Rantala in 1973,
where the ability of Salmonella to colonize the GIT of young chicks was greatly reduced by
administration of a suspension of fecal material from healthy adult chickens86,17. These CE
cultures are a subset of probiotics, and have been extensively researched. The benefits of
probiotics are myriad and include the ability to decrease specific bacterial pathogens, decrease
carcass contamination, increase body weight, increase the integrity of the GIT, decrease
ammonia and urea excretion, reduce inflammatory reactions, improve mineral absorption, and
increase immune function87,8,88,89,90. These characteristics place probiotics in the lead as a
potential replacement for AGP in poultry.
The villus height to crypt depth ratio is thought to be indicative of intestinal health.
Higher ratios indicate a healthier gut due to longer villus length, which is directly linked to
surface area and absorption, while shorter crypt depth is indicative of a reduction of villus
turnover. Awad et al noted that broilers given a Lactobacillus probiotic had significantly higher
villus height to crypt depth ratios than control birds91. Tuomola et al demonstrated that some
probiotic strains of Lactobacillus reduced the adhesion of pathogenic E. coli and S.
Typhimurium to intestinal mucus while others increased mucus binding92. These findings
indicate that not all probiotic strains have similar effects. In cell culture, Bifidobacterium lactis
420 supernatant was able to increase tight junction integrity and prophylactically protect tight
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junctions from damage by E. coli O157:H793. Farnell et al studied the in vitro effects of multiple
probiotic isolates on oxidative burst and degranulation94. The three isolates exhibiting the
greatest effects in vitro were administered individually to day old chicks and heterophils were
isolated for measurement of oxidative burst and degranulation 24 h later. All three treatment
groups showed significant increases in the measured parameters as compared to untreated
controls. Heterophils are important in controlling bacterial pathogens; as such the noted
stimulation of heterophils may be one mechanism by which probiotics are able to reduce
bacterial pathogens within the gut. Metabolites secreted by some strains of Lactobacillus have
been shown to have anti-inflammatory effects95,96 ,97. When these metabolites were introduced
into cell culture they caused a suppression of tumor necrosis factor alpha which could lead to a
decrease of inflammation in the gut96,97. Menard et al reported further that this metabolite is able
to cross the epithelial barrier and may be able to affect cells outside the GIT96. Further,
transcriptional profiling of chickens fed probiotics suggested probiotic-induced differential
regulation of multiple genes affecting innate immunity and apoptosis in the cecae of chickens,
which may be a mechanism by which probiotics affect intracellular pathogens such as
Salmonella98.
Probiotics have been shown to improve the production parameters of commercial poultry.
Vicente et al conducted a study in commercially housed broilers in Mexico to determine what, if
any, contribution a commercially available probiotic culture would have99. The probiotic treated
birds had a 0.9% reduction in mortality, a 2.06% improvement in body weight, and a 3.5%
improvement in feed conversion as compared to non-treated controls99. Torres-Rodriguez et al
evaluated the same probiotic in a similar trial in commercially housed turkeys in the United
States100. An increase in body weight of 190 g and average daily gain of 1.63 g was observed in
19

treated groups when compared to untreated controls. When costs were compared between
treated and untreated groups, the cost per kilogram of meat was reduced by $0.0153 in the
treated group100. Wolfenden et al observed a body weight increase of 8.7% over non-medicated
controls and virtually identical increase as AGP treated birds in a trial conducted in
commercially raised turkeys evaluating Bacillus spore based probiotic cultures101. It was also
observed that birds receiving the probiotic treatment were significantly less likely than nonmedicated controls to be infected with Salmonella, with a rate of recovery of 18% and 48%
respectively101. No differences were observed in the AGP treated group. In addition to lower
incidence of Salmonella, it was also noted that infected turkeys in the probiotic treated group had
a significantly lower concentration of Salmonella in the ceca as compared to non-medicated
controls101.
Available scientific evidence suggests that probiotics may offer an effective alternative to
AGP usage. It is often argued that probiotics do not consistently show performance benefits, and
as such are not a reliable alternative. It is important to note that although AGP improve
performance approximately 70% of the time in production animals, no measurable positive
effects occur in almost one-third of applications102. Despite this observed rate of failure, AGP
are used in abundance. Torres et al reported a similar success rate with a lactic acid bacteriabased probiotic in commercial turkeys103. The study utilized a total of 118 commercial turkey
lots and the probiotic as administered to 60 flocks103. The weights of flocks from farms that
historically ranked in the bottom 75% by the integrator were significantly increased (P ≤ 0.05),
whereas the weights of the flocks sold from the top 25% of farms were not significantly changed
(P ≥ 0.05)103. These data indicate for both AGP and effective probiotics, little positive effect

20

would be anticipated in the best-performing flocks, possibly because these flocks were
performing near maximum potential102,103.
Prebiotics
Prebiotic was defined in 1995 by Gibson and Roberfroid as a non-digestible food
ingredient which beneficially affects the host by selectively stimulating the growth of and/or
activating the metabolism of one or a limited number of health-promoting bacteria in the
intestinal tract, thus improving the host's microbial balance104. Prebiotics are primarily
oligosaccharides based on hexose monosaccharides, including glucose, fructose, galactose, and
mannose with a polymerization degree of between 2 and 20 monosaccharides83. Gibson and
Roberfroid offered several criteria for a food ingredient to qualify as a prebiotic: it had to 1) be
neither hydrolyzed nor absorbed in the upper part of the GIT; 2) be a selective substance for one
or a limited number of beneficial bacteria commensal to the colon, which are stimulated to grow,
are metabolically activated, or both; 3) be able to alter the colonic flora in favor of a healthier
composition; and 4) induce luminal or systemic effects that are beneficial to the host health.104
This definition is rather restrictive and often ingredients are referred to as prebiotics without
fulfilling all four criteria83,105. A 2007 FAO report listed 400 commonly offered and used
prebiotics, such as inulin, fructooligosaccharides, galactooligosaccharides, soy-oligosaccharides,
xylooilgosaccharides, pyrodextrins, isomaltooligosaccharides, and lactulose105. The new,
emerging prebiotic compounds listed included pecticoligosaccharides, lactosucrose, the sugar
alcohols, glucooligosaccharides, levans, resistant starch, xylosaccharides, and soyoligosaccharides, many were previously classified by Gibson and Roberfroid (1995) as not
meeting the qualifications of a prebiotic83.
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The mechanism of action of prebiotics as an alternative to AGP is dependent on the
nature of the compound, but their selective activity on beneficial bacterial populations in the GIT
make them very similar to probiotics104,64. Prebiotic research in poultry has been limited when
compared to human studies, and results are variable depending on the type of prebiotic
examined106. Fructooligosaccharide (FOS) has been the dominant prebiotic studied for poultry
production and has shown the ability to support growth of Lactobacillus and Bifidobacterium,
while reducing Escherichia coli levels in ingesta107. FOS fed to broiler chickens at a
concentration of 0.375% yielded consistent improvement in growth rate and feed efficiency108.
Research indicates that inclusion of lactose in the diet of poultry can increase the efficacy of
lactic acid bacterial based probiotics109,110,100. Poultry lack the ability to produce the enzyme to
digest lactose, making it a prebiotic ingredient. Field trials conducted by Torres-Rodriguez et al
have shown the inclusion of dietary lactose improved the effects of probiotics containing lactic
acid bacteria, as was evidenced by 17.5% increased body weight of turkeys fed lactose in
combination with a probiotic, compared to a 15.5% increase in turkeys fed only the probiotic,
over untreated turkeys100, thus justifying the combination of prebiotics and probiotics to improve
performance.
Synbiotics
A combination of a prebiotic and a probiotic can be defined as a synbiotic111. The
concept is that the combination could improve the survival and growth of the probiotic organism,
because its specific substrate is available for fermentation, resulting in a more robust response106.
There is also evidence that, in some cases, prebiotics impact growth negatively, and this can be
dramatically reversed with the inclusion of a probiotic109. This observation could potentially
explain inconsistent performance data available for prebiotics in poultry109,100. Research
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regarding poultry performance when using synbiotics is limited, but has more consistently shown
positive results than prebiotics alone109,110,100,112,113. The previously mentioned research by
Torres-Rodriguez and co-workers100 exhibiting the increased performance observed with the
lactose/lactic acid bacterial synbiotic application under commercial conditions exhibited body
weight gains far greater than similar pen studies109,110. Vicente et al110 observed that the
inclusion of a synbiotic in absence of enteric challenge resulted in no performance benefit,
potentially explaining the superior performance observed by Torres-Rodriguez et al100 under
field conditions.
Plant Derived Products
Plants, plant extracts, and essential oils (EO) have long been used for food preservation
and medicines114. These products have shown to exhibit many beneficial effects, such as
enhancing the production of digestive secretions, stimulating blood circulation, exerting
antioxidant properties, reducing the levels of pathogenic bacteria, and potentially enhancing the
immune status115. Some of the bioactive antimicrobial chemical forms derived from plants
include terpenoids, phenolics, glycosides, and alkaloids64 Ginger, pepper, coriander, oregano,
rosemary, sage, thyme, cloves, mustard, cinnamon, garlic, citrus, and tobacco are a few
representatives of plant products expressing antibacterial properties83. Many of these same plant
products are favored in homeopathic medicines. Essential oils have displayed inhibitory effects
on a wide variety of bacterial species in vitro, including Campylobacter jejuni, Clostridium
sporogenes, Escherichia coli, Listeria monocytogenes, S. typhimurium, and S. pullorum116,117.
Mitsch et al tested the effects of two different blends of EO on Clostridium perfringens in broiler
chickens118. The two blends contained varying concentrations of EO from thyme (thymol) and
oregano (carvacrol), with consistent levels of clove (eugenol), turmeric (curcumin), black pepper
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(piperin), and were fed at 100 ppm throughout the study. The first blend reduced C. prefringens
in the feces at day 14, 21, and 30; in the upper ileum and ceca on day 14 and 21; and in the
cloaca on day 14118. The second blend reduced C. perfringens in the upper ileum on day 14 and
30 and in the cloaca on day 30118. Additionally, Yucca schidigera extract was shown to have a
synergistic effect when incorporated in the diet of broilers vaccinated against coccidiosis119.
Broilers receiving the extract demonstrated significant improvements to average daily gain and
feed conversion, as well as more rapid early gut development. Studies testing a blend of oregano
and yucca extracts, along with organic minerals, improved average body weights, feed
conversion and mortality of broilers challenged with H. meleagridis120. Another study using the
same blend supplemented in broiler diets, showed a reduction in the severity of intestinal lesions
caused by Eimeria tenella, compared to untreated positive controls.
When considered all together, multiple options exist to provide similar benefits as those
conveyed by AGP. In fact, when administered in combination, it may be possible to improve
upon the health and performance gains delivered by AGP, thus having significant impact on
welfare and profitability in the poultry industry.
Pre-Harvest Carcass Weight Loss (Shrinkage)
Transport of live animals also has important implications in both economic and welfare
areas121. In poultry and other species, economic losses during transport are due to mortality,
carcass shrinkage (carcass dehydration) and carcass condemnation122. Modern poultry producers
have made efforts to minimize losses, but there are several factors that limit interventions. The
primary contributing factor to loss in poultry is shrinkage, which is exacerbated by the practice
of pre-harvest feed withdrawal (FW). Although FW contributes to shrinkage, USDA inspectors
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have a zero tolerance policy when it comes to visible ingesta on poultry carcasses in the
processing plant123. To achieve this standard and minimize ingesta content in the gut of poultry,
producers are required to cease feed intake prior to harvest124. Feed passage time of poultry
dictates the time required to comply with the USDA food safety mandate125,126. Feed withdrawal
prior to processing of poultry is the most commonly employed method to reduce ingesta
contamination during processing125,126. However, shrinkage begins immediately after FW,
resulting in recommendations that slaughter take place within six hours of onset to minimize the
shrink-associated losses127,122. Thus, processing schedules are organized to consider FW effects
on both gut fullness and shrinkage126. Recent trends have placed scrutiny on the impact that feed
restriction in long term and forced FW has on meat type poultry128,129,130,131. Research to
mitigate the problems associated with FW has yet to yield solutions the poultry industry has
adopted125. Special diet formulations have shown success in improving weight retention during
transport132,133,134. Nijdam et al provided diets during the last phase of life with alternative
formulations to provide high energy content, different macronutrient composition, and low crude
fiber content to reduce the negative effects of feed withdrawal and transport, without an
increased content of the digestive tract133. Farhat et al and Rathgeber et al provided a highly
digestible feed supplement during the on-farm FW hours in chickens and turkeys
respectively132,134. While these strategies appear to have created significant benefits, to date they
have not been adopted by the poultry industry.
Shrinkage is greatly compounded by the removal of water during FW135. To combat the
additional shrinkage associated water restriction poultry producers maintain water availability for
as long as possible. Jarquin et al observed that while poultry continue to consume water during
FW, the rate is much lower than when feed is present136. In studies conducted by Wolfenden et
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al broiler chickens show a commercially available OA water treatment product significantly
reduced carcass condemnation at the processing plant and mortality during transportation, with
consistent improvement of average body weights at the farm and at the processing plant137. This
study is the first of its kind that exhibited an OA product had the ability to increase water
consumption. In the present study, this product was used in commercial turkey production to
evaluate shrinkage during FW as well as during the transportation to the processing plant.
Summary
Considering the projected demands for poultry meat and the challenges associated with
increasing production while maintaining market viability, the poultry industry will be forced to
search for ways to improve upon existing standards. The potential loss of one of the main tools
currently being used for performance enhancement, AGP, will require the poultry industry to
make use of existing alternatives, apply existing technologies in different ways, or develop more
effective alternatives. Published reports indicate there are a variety of viable alternatives to
AGPs. The use of probiotics to increase growth rate, reduce disease, and control specific food
borne pathogens has been well documented in a variety of experimental and commercially
available formulations, suggesting they could offer a quick solution to the dilemma.

To date,

the easiest opportunity to improve cost of goods sold has been to focus on the single largest
expense associated with raising poultry, feed, which is reported to contribute 65% of the total
cost138. As grain prices rise and the competition for feed ingredients becomes more intense it is
unlikely the impact of feed efficiency will diminish. However, other opportunities to cut costs or
increase value exist. This can be seen in products such as antibiotic free, organic, or free range
poultry, which sell for a premium price. Exploiting areas of known losses will become necessary
as well, even when the profit contribution is small. Improvements in animal health and welfare
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will be paramount in the effort to maintain profitability, due to their impacts on efficiencies and
costumer acceptance. The ability to supply a product the customer is willing to purchase is a
must. Research presented in the following chapters evaluated commercially available products
for their impact on production parameters and potential to replace AGP in commercial poultry.

27

References
1. The National Chicken Council. U.S. Chicken Industry History. at
http://www.nationalchickencouncil.org/about-the-industry/history/ (accessed 2013)
2. Strausberg, Stephen. From Hills and Hollers. (University of Arkansas, Fayetteville, 1995).
3. History of Poultry Production. at www.uspoultry.org. (accessed 2013)
4. Damerow, G. Storey’s Guide to Raising Chickens: care, feeding, facilities. (Storey
Publishing, North Adams, MA 2010).
5. USDA ERS - Poultry & Eggs: Statistics & Information. at
http://www.ers.usda.gov/topics/animal-products/poultry-eggs/statistics-information.aspx
#.Udh-9G2tzxU. (accessed 2013)
6. NASS - Publications - Trends in U.S. Agriculture. at
http://www.nass.usda.gov/Publications/Trends_in_U.S._Agriculture/Broiler_
Industry/index.asp. (2002)
7. Hoerr, F. J. Pathogenesis of enteric diseases. Poult. Sci. 77, 1150–1155 (1998).
8. Patterson, J. A. & Burkholder, K. M. Application of prebiotics and probiotics in poultry
production. Poult. Sci. 82, 627–631 (2003).
9. Salminen, S. et al. Functional food science and gastrointestinal physiology and function. Br.
J.Nutr. 80, S147 (1998).
10. Diseases of Poultry. (John Wiley & Sons, Blackwell Publishing, Ames, IA 2011).
11. Butine, T. J. & Leedle, J. A. Enumeration of selected anaerobic bacterial groups in cecal and
colonic contents of growing-finishing pigs. Appl. Environ. Microbiol. 55, 1112–1116
(1989).
12. Björkstén, B. The gut microbiota: a complex ecosystem. Clin. Exp. Allergy J. Br. Soc.
Allergy Clin. Immunol. 36, 1215–1217 (2006).
13. Lu, J. et al. Diversity and Succession of the Intestinal Bacterial Community of the Maturing
Broiler Chicken. Appl. Environ. Microbiol. 69, 6816–6824 (2003).
14. Tellez, G., Higgins, S. E., Donoghue, A. M. & Hargis, B. M. Digestive physiology and the
role of microorganisms. J. Appl. Poult. Res. 15, 136–144 (2006).
15. Barnes, E. M. The avian intestinal flora with particular reference to the possible ecological
significance of the cecal anaerobic bacteria. Am. J. Clin. Nutr. 25, 1475–1479 (1972).
28

16. Bjerrum, L. et al. Microbial community composition of the ileum and cecum of broiler
chickens as revealed by molecular and culture-based techniques. Poult. Sci. 85, 1151–1164
(2006).
17. Nurmi, E. & Rantala, M. New Aspects of Salmonella Infection in Broiler Production.
Nature. 241, 210–211 (1973).
18. Koenen, M. E. et al. Immunomodulation by probiotic lactobacilli in layer- and meat-type
chickens. Br. Poult. Sci. 45, 355–366 (2004).
19. Rhee, K.-J., Sethupathi, P., Driks, A., Lanning, D. K. & Knight, K. L. Role of Commensal
Bacteria in Development of Gut-Associated Lymphoid Tissues and Preimmune Antibody
Repertoire. J. Immunol. 172, 1118–1124 (2004).
20. Waksman, S. A. Antagonistic Relations of Microorganisms. Bacteriol. Rev. 5, 231–291
(1941).
21. Sir Alexander Fleming - Biographical. at
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-bio.html.
(accessed 2013)
22. Wong, G. The Aftermath of Penicillin. at
http://www.botany.hawaii.edu/faculty/wong/BOT135/Lect23.htm. (2001).
23. Black, S., Overman, R. S., Elvehjem, C. A. & Link, K. P. The effect of sulfaguanidine on rat
growth and plasma prothrombin. J. Biol. Chem. 145, 137–143 (1942).
24. Nielsen, E. & Elvehjem, C. A. The growth-promoting effect of folic acid and biotin in rats
fed succinylsulfathiazole. J. Biol. Chem. 145, 713–714 (1942).
25. Moore, P. R. et al. Use of sulfasuxidine, streptothricin, and streptomycin in nutritional
studies with the chick. J. Biol. Chem. 165, 437–441 (1946).
26. Jones, F. T. & Ricke, S. C. Observations on the history of the development of antimicrobials
and their use in poultry feeds. Poult. Sci. 82, 613–617 (2003).
27. Jukes, T. H. Antibiotics in Animal Feeds and Animal Production. BioScience. 22, 526–534
(1972).
28. Stokstad, E. L. R., Jukes, T. H., Pierce, J., Page, A. C. & Franklin, A. L. The multiple nature
of the animal protein factor. J. Biol. Chem. 180, 647–654 (1949).
29. Hill, D. C. & Branion, H. D. The Use of an Animal Protein Factor Supplement in a Practical
Poultry Ration. Poult. Sci. 29, 405–408 (1950).
30. Sunde, M. L., Cravens, W. W., Elvehjem, C. A. & Halpin, J. G. An Unidentified Factor
29

Required by Chicks Fed Practical Rations. Poult. Sci. 29, 204–207 (1950).
31. Swenson, M. J. Effect of a Vitamin B12 Concentrate and Liver Meal on Growth and Feed
Efficiency of Chicks Fed an All-Plant Protein Ration. Poult. Sci. 30, 55–62 (1951).
32. Heth, D. A. & Bird, H. R. Growth Response of Chicks to Antibiotics from 1950 to 1961.
Poult. Sci. 41, 755–760 (1962).
33. Bird, H. R. Chick growth response to dietary antibiotics remains undiminished after 30
years. Feedstuffs. 52,40 (1980).
34. Dafwang, I. I., Bird, H. R. & Sunde, M. L. Broiler Chick Growth Response to Antibiotics,
1981–1982. Poult. Sci. 63, 1027–1032 (1984).
35. Graham, J. P., Boland, J. J. & Silbergeld, E. Growth promoting antibiotics in food animal
production: an economic analysis. Public Health Rep. 122, 79 (2007).
36. Waibel, P. E., Abbott, O. J., Baumann, C. A. & Bird, H. R. Disappearance of the Growth
Response of Chicks to Dietary Antibiotics in an ‘Old’ Environment. Poult. Sci. 33, 1141–
1146 (1954).
37. Libby, D. A. & Schaible, P. J. Observations on growth responses to antibiotics and arsonic
acids in poultry feeds. Science. 121, 733–734 (1955).
38. McGinnis, J., Merrill, L. H., Fry, R. E. & Jensen, L. S. Use-History of Antibiotics as Related
to Their Efficacy in Promoting Growth of Turkeys. Poult. Sci. 37, 810–813 (1958).
39. Starr, M. P. & Reynolds, D. M. Streptomycin Resistance of Coliform Bacteria from Turkeys
Fed Streptomycin. Am. J. Public Health Nations Health. 41, 1375–1380 (1951).
40. Elliott, S. D. & Barnes, E. M. Changes in serological type and antibiotic resistance of
Lancefield group D streptococci in chickens receiving dietary chlortetracycline. J. Gen.
Microbiol. 20, 426–433 (1959).
41. Acar, J., Casewell, M., Freeman, J., Friis, C. & Goossens, H. Avoparcin and virginiamycin
as animal growth promoters: a plea for science in decision-making. Clin. Microbiol. Infect.
6, 477–482 (2000).
42. Wegener, H. C. Historical Yearly Usage of Glycopeptides for Animals and Humans: The
American-European Paradox Revisited. Antimicrob. Agents Chemother. 42, 3049 (1998).
43. Uttley, A. H., Collins, C. H., Naidoo, J. & George, R. C. Vancomycin-resistant Enterococci.
Lancet. 1, 57–58 (1988).
44. Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. Plasmid-mediated resistance to
vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319, 157–161
30

(1988).
45. Centers for Disease Control and Prevention (CDC). Nosocomial enterococci resistant to
vancomycin--United States, 1989-1993. Mmwr Morb. Mortal. Wkly. Rep. 42, 597–599
(1993).
46. Witte, W. Medical consequences of antibiotic use in agriculture. Science. 279, 996–997
(1998).
47. Casewell, M. The European ban on growth-promoting antibiotics and emerging
consequences for human and animal health. J. Antimicrob. Chemother. 52, 159–161 (2003).
48. Phillips, I. et al. Does the use of antibiotics in food animals pose a risk to human health? A
critical review of published data. J. Antimicrob. Chemother. 53, 28–52 (2004).
49. Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C. & Murray, B. E. Vancomycinresistant enterococci from nosocomial, community, and animal sources in the United States.
Antimicrob. Agents Chemother. 40, 2605–2609 (1996).
50. Thal, L. A. et al. Characterization of antimicrobial resistance in enterococci of animal origin.
Antimicrob. Agents Chemother. 39, 2112–2115 (1995).
51. Bates, J. Epidemiology of vancomycin-resistant enterococci in the community and the
relevance of farm animals to human infection. J. Hosp. Infect. 37, 89–101 (1997).
52. Wise, R. An overview of the Specialist Advisory Committee on Antimicrobial Resistance
(SACAR). J. Antimicrob. Chemother. 60, i5–i7 (2007).
53. Swann, M. M. The Joint Committee on the Use of Antibiotics in Animal Husbandry and
Veterinary Medicine. (Her Majesty’s Stationery Office, 1969).
54. Cogliani, C., Goossens, H. & Greko, C. Restricting antimicrobial use in food animals:
lessons from Europe. Microbe. 6, 274 (2011).
55. Dibner, J. J. & Richards, J. D. Antibiotic growth promoters in agriculture: history and mode
of action. Poult. Sci. 84, 634–643 (2005).
56. Singer, R. S. & Hofacre, C. L. Potential impacts of antibiotic use in poultry production.
Avian Dis. 50, 161–172 (2006).
57. Castanon, J. I. R. History of the Use of Antibiotic as Growth Promoters in European Poultry
Feeds. Poult. Sci. 86, 2466–2471 (2007).
58. EC Regulation No. 1831/2003. Official Jounal of the European Union. L 268, 29-43
(2003).

31

59. Smith, R. South Korea to ban use of antibiotics in animals feed. at
http://www.meatingplace.com/ArticleRedirector/?code=17s24049&rType=4&allowguest
=true. (2011).
60. Slaughter Asks Fast Food Companies, ‘What’s in the Beef?’. at
http://www.louise.house.gov/index.php?option=com_content&view=article&id
=2662:slaughter-asks-fast-food-companies-whats-in-the-beef&catid=101:2012-pressreleases&Itemid=100070. (2012).
61. Gaskins, H. R., Collier, C. T. & Anderson, D. B. Antibiotics as growth promotants: mode of
action. Anim. Biotechnol. 13, 29–42 (2002).
62. Page, S. W. Antimicrobial Growth Promoters. Current use of antimicrobial growth
promoters in food animals: the benefits, p.19–51. (Wageningen Academic Press,
Wageningen, 2006).
63. Niewold, T. A. The nonantibiotic anti-inflammatory effect of antimicrobial growth
promoters, the real mode of action? A hypothesis. Poult. Sci. 86, 605–609 (2007).
64. Huyghebaert, G., Ducatelle, R. & Immerseel, F. V. An update on alternatives to
antimicrobial growth promoters for broilers. Vet. J. 187, 182–188 (2011).
65. Jukes, H. G., Hill, D. C. & Branion, H. D. Effect of Feeding Antibiotics on the Intestinal
Tract of the Chick. Poult. Sci. 35, 716–723 (1956).
66. Wise, M. G. & Siragusa, G. R. Quantitative analysis of the intestinal bacterial community in
one- to three-week-old commercially reared broiler chickens fed conventional or antibioticfree vegetable-based diets. J. Appl. Microbiol. 60, Suppl. 1, i5–i7 (2006).
67. Chesson, A. Non-starch polysaccharide degrading enzymes in poultry diets: influence of
ingredients on the selection of activities. Worlds Poult. Sci. J. 57, 251–263 (2001).
68. Choct, M. et al. Increased small intestinal fermentation is partly responsible for the antinutritive activity of non-starch polysaccharides in chickens. Br. Poult. Sci. 37, 609–621
(1996).
69. Teirlynck, E. et al. The cereal type in feed influences gut wall morphology and intestinal
immune cell infiltration in broiler chickens. Br. J. Nutr. 102, 1453–1461 (2009).
70. Cherrington, C. A., Hinton, M., Mead, G. C. & Chopra, I. Organic acids: chemistry,
antibacterial activity and practical applications. Adv. Microb. Physiol. 32, 87–108 (1991).
71. Ricke, S. C. Perspectives on the use of organic acids and short chain fatty acids as
antimicrobials. Poult. Sci. 82, 632–639 (2003).
72. Von Engelhardt, W., Bartels, J., Kirschberger, S., Meyer zu Düttingdorf, H. D. & Busche, R.
32

Role of short-chain fatty acids in the hind gut. Vet. Q. 20, Suppl 3, S52–59 (1998).
73. Mroz, Z. Organic acids as potential alternatives to antibiotic growth promoters for pigs. Adv.
Pork Prod. 16, 169–182 (2005).
74. Eklund, T. The antimicrobial effect of dissociated and undissociated sorbic acid at different
pH levels. J. Appl. Bacteriol. 54, 383–389 (1983).
75. Denyer, S. P. & Stewart, G. S. Mechanism of action of disinfectants. Int. Biodeterior.
Biodegrad. 41, 261–268 (1998).
76. Patten, J. D. & Waldroup, P. W. Use of organic acids in broiler diets. Poult. Sci. 67, 1178–
1182 (1988).
77. Thompson, J. L. & Hinton, M. Antibacterial activity of formic and propionic acids in the
diet of hens on Salmonellas in the crop. Br. Poult. Sci. 38, 59–65 (1997).
78. Wolfenden, A. et al. Effect of Organic Acids and Probiotics on Salmonella enteritidis
Infection in Broiler Chickens. Int. J. Poult. Sci. 6, 403–405 (2007).
79. Bugaut, M. Occurrence, absorption and metabolism of short chain fatty acids in the digestive
tract of mammals. Comp. Biochem. Physiol. B 86, 439–472 (1987).
80. Dalmasso, G. et al. Butyrate Transcriptionally Enhances Peptide Transporter PepT1
Expression and Activity. Plos One. 3, 1-14 (2008).
81. Hodin, R. Maintaining gut homeostasis: The butyrate–NF-κB connection. Gastroenterology.
118, 798–801 (2000).
82. Fuller, R. Probiotics. History and Development of Probiotics. (Chapman and Hall, London,
1992).
83. Hume, M. E. Historic perspective: Prebiotics, probiotics, and other alternatives to
antibiotics. Poult. Sci. 90, 2663–2669 (2011).
84. Reid, G. et al. New scientific paradigms for probiotics and prebiotics. J. Clin.
Gastroenterology. 37, 105–118 (2003).
85. Jaeger, R. G. Competitive Exclusion: Comments on Survival and Extinction of Species.
BioScience. 24, 33 (1974).
86. Lloyd, A. B., Cumming, R. B. & Kent, R. D. Prevention of Salmonella Typhimurium
Infection in Poultry by Pretreatment of Chickens and Poults with Intestinal Extracts. Aust.
Vet. J. 53, 82–87 (1977).
87. Ouwehand, A. C., Salminen, S. & Isolauri, E. Probiotics: an overview of beneficial effects.
33

Antonie Van Leeuwenhoek. 82, 279–289 (2002).
88. Revolledo, L., Ferreira, A. J. P. & Mead, G. C. Prospects in Salmonella Control:
Competitive Exclusion, Probiotics, and Enhancement of Avian Intestinal Immunity. J. Appl.
Poult. Res. 15, 341–351 (2006).
89. Flint, J. F. & Garner, M. R. Feeding beneficial bacteria: A natural solution for increasing
efficiency and decreasing pathogens in animal agriculture. J. Appl. Poult. Res. 18, 367–378
(2009).
90. Lillehoj, H. S. & Lee, K. W. Immune modulation of innate immunity as alternatives-toantibiotics strategies to mitigate the use of drugs in poultry production. Poult. Sci. 91, 1286–
1291 (2012).
91. Awad, W. A., Ghareeb, K., Abdel-Raheem, S. & Böhm, J. Effects of dietary inclusion of
probiotic and synbiotic on growth performance, organ weights, and intestinal
histomorphology of broiler chickens. Poult. Sci. 88, 49–56 (2009).
92. Tuomola, E. M., Ouwehand, A. C. & Salminen, S. J. The effect of probiotic bacteria on the
adhesion of pathogens to human intestinal mucus. Fems Immunol. Med. Microbiol. 26, 137–
142 (1999).
93. Putaala, H. et al. Effect of four probiotic strains and Escherichia coli O157:H7 on tight
junction integrity and cyclo-oxygenase expression. Res. Microbiol. 159, 692–698 (2008).
94. Farnell, M. B. et al. Upregulation of oxidative burst and degranulation in chicken heterophils
stimulated with probiotic bacteria. Poult. Sci. 85, 1900–1906 (2006).
95. Isolauri, E., Kirjavainen, P. & Salminen, S. Probiotics: a role in the treatment of intestinal
infection and inflammation? Gut. 50, iii54–iii59 (2002).
96. Ménard, S. et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory
properties after intestinal transport. Gut. 53, 821–828 (2004).
97. Jones, S. E. & Versalovic, J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial
and anti-inflammatory factors. BMC Microbiol. 9, 35 (2009).
98. Higgins, S. E., Wolfenden, A. D., Tellez, G., Hargis, B. M. & Porter, T. E. Transcriptional
profiling of cecal gene expression in probiotic- and Salmonella-challenged neonatal chicks.
Poult. Sci. 90, 901–913 (2011).
99. Vicente, J. L., Aviña, L., Torres-Rodriguez, A., Hargis, B. & Tellez, G. Effect of a
Lactobacillus spp-based probiotic culture product on broiler chicks performance under
commercial conditions. Int J Poult Sci. 6, 154–156 (2007).
100. Torres-Rodriguez, A. et al. Effect of Lactose as a Prebiotic on Turkey Body Weight Under
34

Commercial Conditions. J. Appl. Poult. Res. 16, 635–641 (2007).
101. Wolfenden, R. E. et al. Evaluation of selected direct-fed microbial candidates on live
performance and Salmonella reduction in commercial turkey brooding houses. Poult. Sci.
90, 2627–2631 (2011).
102. Rosen, G. D. Biotechnology in Animal Feeds and Animal Feeding. Antimicrobials in Pig
and Poultry Nutrition. (Wiley-VCH Verlag GmbH, 2007).
103. Torres-Rodriguez, A. et al. Performance and condemnation rate analysis of commercial
turkey flocks treated with a Lactobacillus spp.-based probiotic. Poult. Sci. 86, 444–446
(2007).
104. Gibson, G. R. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota:
introducing the concept of prebiotics. J. Nutr. 125, 1401–1412 (1995).
105. Food and Agriculture Organization of the United Nations. FAO Technical Meeting on
Prebiotics, September 15-16. (2007).
106. Yang, Y., Iji, P. A. & Choct, M. Dietary modulation of gut microflora in broiler chickens: a
review of the role of six kinds of alternatives to in-feed antibiotics. Worlds Poult. Sci. 65,
97 (2009).
107. Xu, Z. R., Hu, C. H., Xia, M. S., Zhan, X. A. & Wang, M. Q. Effects of dietary
fructooligosaccharide on digestive enzyme activities, intestinal microflora and morphology
of male broilers. Poult. Sci. 82, 1030–1036 (2003).
108. Waldroup, A. L., Skinner, J. T., Hierholzer, R. E. & Waldroup, P. W. An evaluation of
fructooligosaccharide in diets for broiler chickens and effects on Salmonellae
contamination of carcasses. Poult. Sci. 72, 643–650 (1993).
109. Douglas, M. W., Persia, M. & Parsons, C. M. Impact of galactose, lactose, and GrobioticB70 on growth performance and energy utilization when fed to broiler chicks. Poult. Sci.
82, 1596–1601 (2003).
110. Vicente, J. et al. Effect of a Lactobacillus Species-Based Probiotic and Dietary Lactose
Prebiotic on Turkey Poult Performance With or Without Salmonella Enteritidis Challenge.
J. Appl. Poult. Res. 16, 361–364 (2007).
111. Schrezenmeir, J. & de Vrese, M. Probiotics, prebiotics, and synbiotics—approaching a
definition. Am. J. Clin. Nutr. 73, 361s–364s (2001).
112. Li, X., Liu, L. & Xu, C. Effects of supplementation of fructo-oligosaccharide and/or
Bacillus Subtilis to diets on performance and intestinal microflora in broilers. Arch. Für
Tierz. 51, 64–70 (2008).

35

113. McReynolds, J. L. et al. Dietary Lactose and its Effect on the Disease Condition of
Necrotic Enteritis. Poult. Sci. 86, 1656–1661 (2007).
114. Zaika, L. L. Spices and Herbs: Their Antimicrobial Activity and Its Determination1. J.
Food Saf. 9, 97–118 (1988).
115. Brenes, A. & Roura, E. Essential oils in poultry nutrition: Main effects and modes of
action. Anim. Feed Sci. Technol. 158, 1–14 (2010).
116. Kim, J., Marshall, M. R. & Wei, C. Antibacterial activity of some essential oil components
against five foodborne pathogens. J. Agric. Food Chem. 43, 2839–2845 (1995).
117. Friedman, M., Henika, P. R. & Mandrell, R. E. Bactericidal activities of plant essential oils
and some of their isolated constituents against Campylobacter jejuni, Escherichia coli,
Listeria monocytogenes, and Salmonella enterica. J. Food Prot. 65, 1545–1560 (2002).
118. Mitsch, P. et al. The effect of two different blends of essential oil components on the
proliferation of Clostridium perfringens in the intestines of broiler chickens. Poult. Sci. 83,
669–675 (2004).
119. Alfaro, D. M. et al. Use of Yucca schidigera Extract in Broiler Diets and Its Effects on
Performance Results Obtained with Different Coccidiosis Control Methods. J. Appl. Poult.
Res. 16, 248–254 (2007).
120. Duffy, C. F, M., Sims & R. Power. Preliminary Evaluation of Dietary NatustatTM Versus
Histostat® (Nitarsone) for Control of Histomonas meleagridis in Broiler Chickens on
Infected Litter. Int. J. Poult. Sci. 3, 753–757 (2004).
121. Grandin, T. Livestock handling and transport. (CABI, New York, 2000).
122. Veerkamp, C. H. Fasting and Yield of Broilers. Poult. Sci. 65, 1299–1304 (1986).
123. Federal Register 9 CFR Part 304, et al. Pathogen Reduction; Hazard Analysis and Critical
Control Point (HACCP) Systems; Final Rule. (1996).
124. Smidt, M. J., Formica, S. D. & Fritz, J. C. Effect of Fasting Prior to Slaughter on Yield of
Broilers. Poult. Sci. 43, 931–934 (1964).
125. Duke, G. E., Basha, M. & Noll, S. Optimum duration of feed and water removal prior to
processing in order to reduce the potential for fecal contamination in turkeys. Poult. Sci.
76, 516–522 (1997).
126. Sams, A. R. Poultry Meat Processing. (CRC Press, Boca Raton, 2001).
127. Benibo, B. S. & Farr, A. J. The Effects of Feed and Water Withdrawal and Holding Shed
Treatments on Broiler Yield Parameters. Poult. Sci. 64, 920–924 (1985).
36

128. Mench, J. A. Broiler breeders: feed restriction and welfare. Worlds Poult. Sci. J. 58, 23–29
(2002).
129. Keshavarz, K. & Quimby, F. W. An Investigation of Different Molting Techniques with an
Emphasis on Animal Welfare. J. Appl. Poult. Res. 11, 54–67 (2002).
130. Fisher, A. D., Colditz, I. G., Lee, C. & Ferguson, D. M. The influence of land transport on
animal welfare in extensive farming systems. J. Vet. Behav. Clin. Appl. Res. 4, 157–162
(2009).
131. Delezie, E., Swennen, Q., Buyse, J. & Decuypere, E. The Effect of Feed Withdrawal and
Crating Density in Transit on Metabolism and Meat Quality of Broilers at Slaughter
Weight. Poult. Sci. 86, 1414–1423 (2007).
132. Farhat, A. et al. A low residue nutritive supplement as an alternative to feed withdrawal in
broilers: efficacy for gastrointestinal tract emptying and maintenance of live weight prior to
slaughter. Poult. Sci. 81, 1406–1414 (2002).
133. Nijdam, E., Lambooij, E., Nabuurs, M. J. A., Decuypere, E. & Stegeman, J. A. Influences
of Feeding Conventional and Semisynthetic Diets and Transport of Broilers on Weight
Gain, Digestive Tract Mass, and Plasma Hormone and Metabolite Concentrations. Poult.
Sci. 85, 1652–1659 (2006).
134. Rathgeber, B. M., MacIsaac, J. L. & MacKenzie, M. E. Feeding Turkeys a Highly
Digestible Supplement During Preslaughter Feed Withdrawal. Poult. Sci. 86, 2029–2033
(2007).
135. Salmon, R. E. Effect of food and water deprivation on live‐weight shrinkage, eviscerated
carcass yield and water absorption during chilling of Turkey carcasses. Br. Poult. Sci. 20,
303–306 (1979).
136. Jarquin, R. L. et al. The Evaluation of Organic Acids and Probiotic Cultures to Reduce
Salmonella enteriditis Horizontal Transmission and Crop Infection in Broiler Chickens. Int.
J. Poult. Sci. 6, 3 (2007).
137. Wolfenden, A. D. et al. Effect of an Organic Acid Product During Feed Withdrawal on
Broiler Mortality, Shrinkage and Carcass Condemnation Following Transport to
Processing. Int. J. Poult. Sci. 6, 497–500 (2007).
138. Dozier, W. A., Kidd, M. T. & Corzo, A. Dietary Amino Acid Responses of Broiler
Chickens. J. Appl. Poult. Res. 17, 157–167 (2008).

37

Chapter III
EVALUATION OF DIRECT-FED MICROBIALS AS ALTERNATIVES TO
ANTIBIOTIC GROWTH PROMOTERS IN MODERN POULTRY PRODUCTION

C. M. Pixley1, B. M. Hargis2, G. Tellez2, and R. E. Wolfenden1

Key words: Probiotics, DFM, Bacillus, Broiler, Performance, Alternative to AGP, Antibiotic
Free, AGP Free
Running Title: DFM as alternatives to AGP
Primary Audience: Researchers, Nutritionists, Feed Manufacturers, Producers, Veterinarians

1

Current address: Pacific Vet Group-USA, Inc., 2135 Creek View, Fayetteville, AR 72704

2

Current address: University of Arkansas, Center of Excellence for Poultry Science, University

of Arkansas, Fayetteville, AR 72701
3

Corresponding Author: rwolfended@pacificvetgroup.com

38

III.

EVALUATION OF DIRECT-FED MICROBIALS AS ALTERNATIVES TO
ANTIBIOTIC GROWTH PROMOTERS IN MODERN POULTRY
PRODUCTION

Summary
In a series of experiments the suitability of replacing antibiotic growth promoters (AGP)
with direct-fed microbials (DFM) was evaluated. In experiments 1 and 2, broiler chickens were
kept in floor pens on used litter and grown to market age. Experiment 1 compared a standard
diet containing no AGP or DFM, standard diet plus 50 grams per ton of bacitracin methylene
disalicylate (BMD), or a standard diet including Sporulin® - a commercially available Bacillus
subtilis spore-based DFM. Experiment 2 compared standard diets containing either 50 grams per
ton of BMD or Sporulin. Experiment 3 was conducted in commercial broiler houses comparing
the integrator’s AGP free diet with a diet containing Sporulin. The data from these three
experiments indicate that inclusion of a Bacillus DFM can improve performance as compared to
an AGP free diet or one containing traditional AGP. This suggests that as AGP availability
becomes limited, poultry producers may look to DFM as an alternative to maintain efficient
production.
Description of Problem
Recent trends in the animal agriculture industry have been pushing for production
methods which are perceived to be more natural and sustainable. These trends are primarily
shaped by social pressures from consumers in the general public. As a result, the industry is
looking for ways to reduce or eliminate the inclusion of chemotherapeutic compounds with a
negative public perception. Antibiotic growth promoters (AGP) in particular have been singled
out due to the emergence of antibiotic resistant bacteria over the years1 and the prevalence of
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press regarding these organisms in popular media. While the major driving force behind the
movement is consumer demand, in some cases, government organizations have enacted bans on
inclusion of AGP. In 2006, a full ban on the use of AGP was enacted in the European Union 2
and in 2011 South Korea followed suit3. While these two cases are significant, the overall
driving force behind the movement has been consumer driven and the response of food providers
to consumer trends. Many popular restaurant chain companies such as McDonald’s, Kentucky
Fried Chicken, Wendy’s, Hardees, Subway and Chipotle have required suppliers to guarantee
meat they purchase has been grown without the inclusion of AGP in feed4. The scientific debate
over AGP is largely irrelevant to the negative public perception. As a result, the poultry industry
has been, and will continue to be, incentivized to limit the use of AGP and to seek alternatives.
The exact percentage of companies currently utilizing AGPs in feed is not known.
Published estimates from 2000 state that the majority of broiler feeds were incorporating some
AGP, but usage rate was in decline5. Bacitracin methylene disalicylate (BMD) was the most
abundantly used AGP. It is a branched, cyclic decapeptide compound that interferes with cell
membrane function, suppresses cell wall formation by preventing the formation of peptidoglycan
strands, and inhibits protein synthesis6. BMD is approved by the United States Food and Drug
Administration for inclusion in broiler feeds for the purpose of increasing rate of weight gain,
improving feed efficiency, and as an aid in the prevention of necrotic enteritis caused by or
complicated by Clostridium spp. or other organisms susceptible to BMD7. Contemporary
scientific documentation regarding the efficacy of BMD as an AGP is limited. A literature
review of BMD use in broilers since 2000 indicates that in pen trials on used litter BMD
provides an increase in growth rate of ≤ 1.7% in male broilers and slightly better performance in
females8,9,10. Previous review of the efficacy of AGP has reported varying levels of performance
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benefits over time, and it is interesting to note that in approximately one third of all applications
there is no measurable performance benefit 11.
Sporulin, a commercially available Bacillus subtilis spore based DFM, has been marketed
in the United States since 2010 as an option for poultry producers looking to replace AGP. It
contains three strains of B. subtilis selected for their ability to propagate in the intestinal tract of
poultry, improve growth rates, and compete with pathogenic bacteria12,13,14. In this study,
experiments were conducted to assess the suitability of Sporulin as an alternative to commonly
used AGPs and to evaluate the impact of including DFMs in AGP free production.
Materials and Methods
Experiment 1
Day of hatch male broiler chicks (Ross X Ross 708) were obtained from a commercial
hatchery and allocated randomly in floor pens containing used litter at a density of 0.83 ft2 per
bird.

All chicks received standard vaccinations in the hatchery. Chicks were allocated into

groups of 20 with 10 replicates per treatment. Treatments consisted of 50 grams per ton of
BMD, 1x106 CFU/g of Sporulin included continuously in the diet, or a control diet containing no
AGP or DFM. A commercial diet that met or exceeded NRC requirements and water were
provided ad libitum through the duration of the experiment. The broilers were raised to 46 days
of age and data was collected throughout the trial period.
Experiment 2
As in Experiment 1, day of hatch commercial cross male broiler chicks (Cobb) were
obtained from a commercial hatchery and allocated randomly in floor pens containing used litter
at a density of 0.83 ft2 per bird.

All chicks received standard vaccinations in the hatchery.

Chicks were allocated into groups of 54 with 12 replicates per treatment. Treatments consisted
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of either 50 g per ton of BMD, or 1x106 CFU/g of Sporulin included continuously in the diet.
Feed and water were provided ad libitum through the duration of the experiment. The broilers
were raised to 38 days of age and data was collected throughout the trial period.
Experiment 3
A third experiment was conducted on commercial cross broilers (Cobb) under field
conditions comparing an industry standard antibiotic free program to a program modified to
improve enteric health. The veterinarian-designed enteric health program included continuous
treatments with an in-feed DFM (Sporulin) in combination with periodic treatment with a water
administered probiotic (FloraMax®-B11) on days 1, 8 and 18 and a water acidifier (OptimizerTM)
on days 7 and 17. The treatment group, consisting of 7 flocks (225,000 birds), was compared to
a control group of 12 flocks (400,000 birds). The experiment was conducted on a single farm
location with multiple houses, where treatments were randomly assigned among houses. The
broilers were raised to an average of 33 days of age and data was collected throughout the trial
period.
Statistical Analysis
Differences in measured parameters between groups were determined by ANOVA using
the GLM procedure. Significant differences (P <0.05) were further separated using Duncan’s
multiple range test. All statistical analysis was conducted using the SAS v9.3 edition15.
Results and Discussion
In Experiment 1 no significant differences were observed, however, numerical
improvement was consistently observed in the group receiving Sporulin compared to other
groups (Table1). At termination, BW was heaviest in the Sporulin group (3.53 kg) as compared
to the Control group (3.48 kg) and BMD treated group (3.47 kg). Average daily gain was
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greatest in birds fed a diet containing Sporulin (76.7 g/d), followed by the control diet (75.7 g/d)
and BMD treated diet (75.4 g/d). Similar trends were observed in FCR, birds treated with
Sporulin (1.71) outperformed birds in the BMD (1.76) and Control (1.77) groups. The observed
improvement in FCR, while not significant, had a P-value = 0.06 for Sporulin versus Control and
P = 0.15 for Sporulin versus BMD. FCR was adjusted for mortality and to a standard body
weight of 3.175 kg using a ratio of .01 points FCR: 23 g BW.
It was hypothesized that the low number of birds per group and the minimal number of replicates
resulted in numeric but not significant differences in Experiment 1. Therefore, in Experiment 2,
the design was altered in an attempt to more fully evaluate the hypothesis that Sporulin was an
effective alternative to AGP. In this altered experimental design significant differences were
observed in FCR and the previously observed trend of superior performance in broilers
consuming Sporulin was confirmed. BW and ADG at termination were heavier in the Sporulin
treated groups (2236 g: 57.6 g/day) versus those receiving BMD (2207 g: 56.8 g/day) with a P
value of 0.07. FCR was significantly (P≤0.05) improved in the DFM treated groups (1.60)
versus the BMD groups (1.68). FCR was adjusted to a standard body weight of 2.267 kg using a
ratio of .01 points FCR: 27.2 g BW.

A summary of the data can be found in Table 2.

Under commercial flock conditions in Experiment 3, it was observed that the treated flocks had
significantly (P≤0.05) higher BW and ADG (1726 g: 49.61 g/day) versus the control flocks
(1540 g: 45.22 g/day; Table 3). Improvement (P<0.05) in FCR from 1.66 in treated flocks to
1.88 in control flocks was also observed (Table 3). Feed conversion ratio was adjusted to a
standard body weight of 1.6 kg using a ratio of .01 points FCR: 27.2 g BW.
The beneficial effects of bacteria have been observed extensively throughout human
history, most notably by Nobel prize winner Eli Metchnikoff, who promoted the idea that yogurt
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and the bacteria it contained contributed to the longevity of Bulgarian peasants16. Over time
these beneficial bacterial cultures have been referred to using different terms including,
competitive exclusion cultures, probiotics and direct fed microbials17. The term “direct-fed
microbial” is commonly differentiated in animal agriculture as referring to beneficial live
microorganisms that are consumed in the feed of animals intended for food production and is
often used synonymously with probiotic, although technically this term was generated by an
FDA definition in a compliance policy guide18. Probiotics can be defined as live
microorganisms which when administered in adequate amounts confer a health benefit on the
host19. The beneficial effects may include the reduction or exclusion of pathogenic bacteria, this
is what was previously referred to as competitive exclusion (CE) by Jaeger in 197420. The term
CE has also been adopted to describe a similar phenomenon described by Nurmi and Rantala in
1973, where the ability of Salmonella to colonize the gastro-intestinal tract of young chicks was
greatly reduced by the administration of a suspension of fecal material from healthy adult
chickens21,22. These CE cultures are a subset of probiotics, and have been extensively
researched. The benefits of probiotics in poultry are myriad and include the ability to decrease
specific bacterial pathogens, decrease carcass contamination, increase body weight, increase the
integrity of the gastrointestinal tract, decrease ammonia and urea excretion, reduce inflammatory
reactions, improve mineral absorption, and increase immune function23,24,25,26,27. These
characteristics place probiotics in the lead as a potential replacement for AGP in poultry.
Probiotics have been shown to improve the production parameters of commercial poultry,
consistent with the data presented here. Vicente et al conducted a study in commercially housed
broilers in Mexico to determine what if any contribution a commercial available probiotic culture
would have28. The probiotic treated bird had a 0.9% reduction in mortality, a 2.06%
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improvement in body weight, and a 3.5% improvement in feed conversion as compared to nontreated controls. Torres-Rodriguez et al evaluated the same probiotic in a similar trial in
commercially housed turkeys in the United States29. An increase in body weight of 190 grams
and average daily gain of 1.63 g was observed in treated groups when compared to untreated
controls. When costs were compared between treated and untreated groups, the cost per
kilogram of meat was reduced by $0.0153 in the treated group29. Wolfenden et al observed a
body weight increase of 8.7% over non-medicated controls and virtually identical to AGP treated
birds in a trial conducted in commercially raised turkeys evaluating Bacillus spore based
probiotic cultures14. It was also observed that birds receiving the probiotic treatment were
significantly less likely than non-medicated controls to be infected with Salmonella with a rate of
recovery of 18% and 48% respectively14. No differences were observed in the AGP treated
group. In addition to lower incidence of Salmonella, it was observed that infected turkeys in the
probiotic treated group had a significantly lower concentration of Salmonella in the ceca as
compared to non-medicated controls14.
Available scientific evidence suggests that probiotics may offer an effective alternative to
AGP usage. It is often argued that probiotics do not consistently show performance benefits, and
as such are not a reliable alternative. It is important to note that although AGP improve
performance approximately 70% of the time in production animals, no measurable positive
effects occur in almost one-third of applications11. Despite this observed rate of failure, AGP are
used in abundance. Torres et al reported a similar success rate with a lactic acid bacteria-based
probiotic in commercial turkeys30. The study utilized a total of 118 commercial turkey lots and
the probiotic was administered to 60 flocks30. The weights of the flocks from farms that
historically ranked in the bottom 75% by the integrator were significantly increased (P ≤ 0.05),
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whereas the weights of the flocks sold from the top 25% of farms were not significantly changed
(P ≥ 0.05)30. These data indicate for both AGP and effective probiotics, little positive effect
would be anticipated in the best-performing flocks11,30.
Data from these pen trials and a large commercial field trial clearly indicated that
Sporulin was a suitable candidate as a replacement to AGP, showing favorable results when
compared to the most commonly used AGP, BMD, in conventional poultry production. Sporulin
consistently increased performance over BMD in all experiments, increasing BW by greater than
1.5% and an improvement in FCR of greater than 2.3%. Sporulin inclusion also showed strong
performance benefits when incorporated into AGP free production. Growth rates of broiler
chickens under existing industry conditions increased dramatically. BW increased by 9.7% and
FCR improved by 7.8%. Feed costs contribute 65% of the total price of rearing poultry,
amplifying the significance of improved FCR31. When poultry producers achieve improvements
in FCR, the cost of goods is directly lowered, and even modest changes can account for
significant profitability adjustments. Probiotics are well within the category of socially accepted
performance enhancers, and seem to offer a strong solution to the pending quandary on how to
replace AGP.
Conclusions and Applications
1.

Inclusion of Sporulin in the diet significantly improved BW, FCR and ADG.

2. This specific Bacillus DFM may provide a viable alternative to the use of AGP in
broilers.
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Tables
Table 1: Experiment 1 - Evaluation of Sporulin® as an alternative to BMD as an AGP
Treatment

BW (kg)

ADG (g)

FCR1

Standard Diet
(No AGP, No DFM)

3.48a±0.03

75.7a±0.74

1.77a±0.02

Standard Diet
+ 50 g per ton BMD2

3.47a±0.03

75.4a±0.73

1.76a±0.03

Standard Diet
+ Sporulin3

3.53a±0.03

76.7a±0.68

1.71a±0.024

1

Adjusted for mortality and to a standard body weight of 3.175 kg using a ratio of .01 points
FCR: 23 g BW
2

Bacitracin methylene disalicylate

3

Pacific Vet Group-USA, Inc.

4

P = 0.06 vs. Standard Diet; P = 0.15 vs Standard Diet + BMD

a,b

denote significant statistical difference (P ≤ 0.05)

n = 10 pens per treatment, 20 birds per pen
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Table 2: Experiment 2 - Evaluation of Sporulin® as an alternative to BMD as an AGP
Treatment

BW (kg)

ADG (g)

FCR1

Standard Diet
+ 50 g per ton BMD2

2.20a±0.007

56.8a±0.19

1.68a±0.005

Standard Diet
+ Sporulin3

2.23a±0.0134

57.6a±0.364

1.60b±0.006

1

Adjusted for mortality and to a standard body weight of 2.267 kg using a ratio of .01 points
FCR: 27.2 g BW
2
3
4

Bacitracin methylene disalicylate
Pacific Vet Group-USA, Inc.
P = 0.07 vs. Standard Diet + BMD

a,b

denote significant statistical difference (P ≤ 0.05)

n = 12 pens per treatment, 54 birds per pen
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Table 3: Experiment 3 - Evaluation of probiotics as an non-antibiotic performance enhancer as
part of an enteric health program in commercial broilers

1

Treatment

Age (d)

BW (kg)

ADG (g)

FCR1

Standard Diet
(No AGP, No
DFM)

32.8a±0.92

1.54b±0.034

47.1b±0.001

1.88a±0.05

Standard Diet
+ probiotics2

33.7a±1.55

1.69a±0.047

51.2a±0.001

1.66b±0.04

Adjusted to a standard body weight of 1.6 kg using a ratio of .01 points FCR: 27.2 g BW

2

Sporulin® included in all feed; FloraMax®-B11 treatment in water on day 1, 8, and 18;
OptimizerTM treatment on day 7 and 17 – all used according to label requirements
a,b

denote significant statistical difference (P ≤ 0.05)

Standard diet n = 12 flocks, 400,000 birds total
Standard diet + probiotics n = 7 flocks, 225,000 birds total
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IV.

EVALUATION OF A COMMERCIALLY AVAILABLE ORGANIC ACID
PRODUCT DURING FEED WITHDRAWAL AND ITS RELATION TO
CARCASS SHRINK IN COMMERCIAL TURKEYS

Abstract
The transport of live animals has important economic and welfare implications. A
commercially available organic acid product (Optimizer™) was added to the drinking water of
commercial hen turkeys during pre-slaughter feed withdrawal (FW) in two trials. In trial 1, a
total of 60 trailers from treated (OA) or control non-treated turkey houses were evaluated.
Turkey farmers initiated water treatment on the day before pick up (8-12 h treatment according
to label directions). Investigators recorded trailer numbers as they were loaded out of each house
to confirm which trailers contained treated birds vs. control non-treated birds. Individual trailer
weights were recorded upon arrival to the processing plant and again immediately prior to live
hang. A significant reduction in rate of weight loss during holding at the processing plant was
observed in the treated turkeys (719 g/min per OA treated trailer vs. 845 g/min per control
trailer). In trial 2, two commercial market age turkey houses were selected and in each house,
400 birds were weighed and recorded as a representative sampling. The treated house received
OA administered according to manufacturer’s directions continuously for 19 h. At the end of this
time, 400 birds were weighed and recorded as a representative sampling. A significant (p<0.05)
improvement of average body weights was observed in treated turkeys during 19 h (125 g treated
vs. 35 g control), an average of 90 grams difference. Experiments are ongoing to measure water
consumption during the FW that may explain the reduction in carcass shrinkage during
transportation to the processing plant and increased body weights at the farm by increasing
hydration of turkeys treated with OA.
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Introduction
The transport of live animals has important implications in both economic and welfare
areas1. In poultry and other species, economic losses during transport are due to mortality,
carcass shrinkage (carcass dehydration) and carcass condemnation2. Although pre-transport feed
withdrawal (FW) contributes to carcass shrinkage, FW prior to processing of poultry is simple
and is commonly employed to reduce ingesta contamination during processing3,4,5. However,
shrinkage begins immediately after FW2,6,7, resulting in recommendations that slaughter take
place within 4-6 h after FW to minimize the shrink-associated losses. Thus, processing
schedules should consider FW effects on both gut fullness and shrinkage. Previously our
laboratory conducted a study in broiler chickens showing a commercially available water
treatment product significantly reduced carcass condemnation at the processing plant and
mortality during transportation, with consistent improvement of average body weights at the
farm and at the processing plant8. In the present study, this product was used to evaluate
shrinkage during FW as well as during the transportation to the processing plant.
Materials and Methods
Organic acids: A commercially available water treatment product (OptimizerTM) was
used in the drinking water according to manufacturer’s directions. This commercial product is a
proprietary combination of organic acids and flavoring agents. Previous publications have also
shown this product, under experimental conditions, to reduce Salmonella colonization in crop
and cecal tonsils without affecting water consumption in chickens9,10.
Trial 1
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Trial 1 was conducted with a total of 60 trailers from treated and control non-treated
turkey houses. Each trailer carried an average of 2100 market age turkeys from a commercialcross turkey line. These turkeys were being raised by contract farmers for an integrated turkey
company in the state of Arkansas, USA. Water treatment was initiated at 9 PM on the day before
pick up with sufficient OA stock solution to last 8-12 h, during the time of FW (time off feed).
Investigators recorded trailer numbers as they were loaded out of each house to confirm which
birds received the OA vs. controls. Individual trailer weights were recorded upon arrival at the
processing plant (Time 1) and immediately prior to live hang (Time 2).
Formulas used
Yard Time = Time 2 - Time 1
Shrink = Trailer weight at Time 1 – Trailer weight at Time 2
Shrink/minute = Shrink/Yard Time
% Shrink/minute = ((Shrink/Trailer weight at Time1)/Yard Time in minutes)100
Time off feed = Time 2 - Time when feed access was removed
Value of treatment = (Control Shrink-Treatment Shrink) (Value of the carcass per Kg)
Benefit to Cost Ratio = Value of treatment/OA product cost
Trial 2
In trial 2, two commercial market age turkey houses were selected and a representative
sample (n = 400) was weighed and recorded. Portable fencing was used to corral approximately
20 turkeys at approximately 20 sites for weighing. The treated house received the mix of OA
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continuously for 19 h. At the end of this time, a representative sample (n = 400) was weighed
and recorded.
Data analysis
In trial 1, data collected were subjected to one-way analysis of variance for carcass
shrinkage during holding at the processing plant yard prior to live hang and significant
differences between means were further separated using Duncan's multiple range test11. In trial 2,
a two by two factorial analysis was performed to evaluate body weights before and after
treatment in the OA treated vs. control non-treated turkeys. Statistical significance was
designated at p<0.05 in both trials.
Results and Discussion
Economic losses during transport are due to mortality, particularly of pigs and poultry,
carcass bruising and shrinkage (loss of weight) and reductions in meat quality12. Table 1 shows
the effect of this OA product administered during turkey FW on carcass shrinkage during
holding at the processing plant in trial 1. A significant reduction in carcass shrinkage in the
turkeys that received the mix of OA was observed when compared with the control non-treated
birds. There were no significant differences in the time off feed in the FW period or the transit
time of the trailers from the farms to the processing plant between the treated and the control
non-treated birds. Table 2 summarizes the effect of OA during feed withdrawal on body weights
of commercial turkeys before and after the treatment in trial 2. A significant increase in the body
weight of the treated turkeys that received OA was observed when compared with the nontreated turkeys, with 90 grams gained in only 19 h of treatment with OA. Economic estimates in
commercial broiler chickens that received a similar treatment of OA during FW suggested a ten59

fold return on investment after deducting the cost of the OA product8. In the present study, the
benefit to cost ratio was estimated at greater than 6.5:1. Note that weight loss during
transportation from farm to the processing plant was not measured. The losses were only
quantified during the time the trailers spent in queue at the processing plant.
In areas where there are regulatory and consumer issues with Salmonella contamination
of carcasses, there may be an additional advantage to some OA products. This product has
shown to decrease Salmonella in market age broilers when administered during the pre-slaughter
FW period9. Previous research has suggested that administration of lactic acid during the preslaughter FW, effective for reducing crop contamination with Salmonella at relatively high
concentrations, could discourage water consumption and lead to excessive carcass shrinkage13.
While this evidence was shown when using lactic acid alone, the product evaluated in the present
study is reported to contain a proprietary combination of organic acids and flavorants where
water consumption is not discouraged. Flavoring agents claimed by the manufacturer have not
been released or evaluated. Organic acids are a readily available energy source for both the birds
and gut microflora; therefore, it is important that the organic acids be administered in sufficient
concentrations to be bactericidal, but low enough concentrations to be voluntarily consumed by
the birds.
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Tables
Table 1: Evaluation of the effect of organic acids during feed withdrawal on carcass shrink
during holding of commercial turkeys at the processing plant in trial 1
Control
Treated
a
Yard Shrink per trailer per minute (grams)
845 ±27.1
719b±22.6
a
Shrink per minute (%)
2.8 ±0.045
2.4b±0.044
Transit time (min)
71a±5.96
68a±6.08
a
Time off feed (min)
809.14 ±40.1
726.33a±30.9
Difference of shrink per minute between groups
126 grams
Values are presented as mean ± SE. Different letters within rows of experimental columns
indicate significant differences between treatments (P<0.05).

62

Table 2: Evaluation of organic acids during feed withdrawal on body weights on commercial
turkeys before and after treatment in trial 2
Body weights before Body weights after
Difference in
treatment (0 h)
treatment (19 h)
body weights
Control
6359b,x±40
6394b,y±35
35 grams
b,x
a,x
Treated
6456 ±36
6581 ±33
125 grams
Difference in body weights
97 grams
187 grams
90 grams
Values are presented as mean ± SE. Different letters within rows of experimental columns
indicate significant differences between treatments (P<0.05). Different letters within rows (a,b)
or within columns (x,y) indicate significant differences
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V.

Conclusions
Historically, AGP have been added to poultry feeds because of their proven benefits on

growth parameters1. Recent consumer trends, largely based on controversial arguments that
AGP pose a risk to human health due to increased antibiotic resistance in pathogens2, have begun
demanding that food animals be raised without the aid of AGP. Additionally, AGP have already
been removed as an option for production by government agencies in South Korea3 and Europe4,
and producers are increasingly concerned with the possibility of the same occurrence in the US,
which has spurred an increasing interest in research aimed to provide viable alternatives for
AGP. However, the mechanism of AGP action(s) is not well known5, which has led to multiple
areas of focus in the search for replacement technologies6, and it is at least somewhat likely that
combinations of such emerging technologies will be needed to realize the same benefits
conferred by AGP. The objective of the enclosed body of work was to establish what, if any,
impact the use of specific non-traditional technologies might have on modern poultry production.
These technologies would need to meet the criteria of a discerning market that is focused on
removal of chemotherapy and improving the welfare of animals used in the animal agriculture
business. In order to be widely accepted, these technologies would also need to improve the
efficiency and costs associated with raising poultry.
In Chapter 3, the suitability of a Bacillus based DFM to replace AGP was evaluated.
Data from pen trials and a large commercial field trial clearly indicated that the DFM was a
suitable candidate as a replacement to AGP, showing favorable results when compared to the
most commonly used AGP (BMD) in conventional poultry production. The DFM consistently
increased performance over BMD in all experiments, increasing BW by greater than 1.5% and an
improvement in FCR of greater than 2.3%. DFM inclusion also showed strong performance
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benefits when incorporated into AGP free production. Growth rates of broiler chickens under
existing industry conditions increased markedly. BW increased by 9.7% and FCR improved by
7.8%. When poultry producers achieve increases in FCR, the cost of goods is directly lowered.
Feed costs contribute 65% of the total price of rearing poultry7, amplifying the significance of
improved FCR. Probiotics are well within the category of socially accepted performance
enhancers, and seem to offer a strong solution to the pending quandary on how to replace AGP.
The second set of experiments, presented in Chapter 4 evaluated an OA product to
determine if it would improve water consumption during pre-harvest feed withdrawal and reduce
shrinkage during transportation from farm to processing plant. During the feed withdrawal
period, water consumption decreases, which leads to welfare concerns and weight loss that has a
significant impact on profitability. Previously published research from a large field trial in
broilers indicated the impact of this commercially available OA product was significantly
correlated to decreased transport associated losses, increasing profitability for the poultry
company8. The findings in this study were similar when the product was applied in commercial
turkeys, where OA-treated turkeys were 90 grams heavier than untreated turkeys after the feed
withdrawal period. Additionally, shrinkage at the processing facility while waiting in the
holding area was significantly reduced in turkeys that received OA during feed withdrawal. The
OA product showed significant reduction in FW and transport associated losses, providing a
strong financial return to the poultry producer.
Indications are that in these specific studies involving commercially available products,
clear scientific evidence supports welfare and financial motivations to incorporate these select
non-traditional technologies into poultry production programs. Both products are based on
technologies that are commonly found in a variety of animal and human nutrition, and generally
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well accepted as safe by the public and government entities but have yet to be fully incorporated
into industry standard practice. While they may not individually serve to effectively replace
AGP and resolve poor management, presented evidence suggests that in production flocks, they
can help improve production parameters of poultry. Due to the complex nature of rearing highdensity flocks, it may be reasonable to assume that no single technology will have as great of an
influence as AGP on the advancement of food animal production. However, combinations of
alternative technologies may prove to effectively improve production parameters and well-being
of the poultry and livestock industries and may possibly have additive or synergistic effects
beyond those seen with AGP. Ongoing research will focus on combinations of such alternatives
and further improvement of these existing products.
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